Skip to content
Screener

EPS (Diluted) at other companies

CVS Health logo
CVS HealthCVS
$2.31+189%
UnitedHealth Group logo
UnitedHealth GroupUNH
$6.04+61.5%
TOI
TOITOI
-$0.02+90.5%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$0.67+379%
Health Catalyst logo
Health CatalystHCAT
-$0.55+6.8%
Elevance Health logo
Elevance HealthELV
$6.71-13.1%

Segments

By segment

See full
Reportable segment-$51,090,000.00

Other financials

Income statement

See full
Revenue$652.5M+46.9%
Gross profit$80.8M-19.5%
Operating income-$9.6M-716%
Net income-$28.4M-42.6%

Balance sheet

See full
Cash & equivalents$115.7M-23.4%
Total debt$970.4M+13.7%
Total equity$383.2M-57.2%
Total assets$2.0B-19.9%

Cash flow

See full
Operating cash flow-$9.3M+69.3%

Valuation

See full
Market cap$446.58M-58.2%
Enterprise value$1.3B-26.5%
P/S0.2×-0.3×

Profitability

See full
Gross margin17.2%+0.9pp
Operating margin-20.4%-22.4pp
Net margin-24.1%-35.8pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-79%-99.2pp
Debt / equity2.5×+1.6×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:53 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628908-26-000086
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Dividends and accretion of Series A Preferred Stock(31,193)(38,825)
Net loss attributable to common shareholders of Evolent Health, Inc.$(28,364)$(51,090)$(54,996)$(123,340)
Loss per common share
Basic and diluted$(0.25)$(0.44)$(0.49)$(1.07)
Weighted-average common shares outstanding
Basic and diluted112,542115,882112,225115,600
Comprehensive loss
Net loss attributable to common shareholders of Evolent Health, Inc.$(28,364)$(51,090)$(54,996)$(123,340)

Item 1. Financial Statements

FAQ

What is Evolent Health, Inc.'s EPS (diluted)?
Evolent Health, Inc. (EVH) reported EPS (diluted) of -$0.25 in Q2 2026.
How has Evolent Health, Inc.'s EPS (diluted) changed year-over-year?
Evolent Health, Inc.'s EPS (diluted) increased by 43.2% year-over-year, from -$0.44 to -$0.25.
What is the long-term trend for Evolent Health, Inc.'s EPS (diluted)?
Over 4 years (2021 to 2025), Evolent Health, Inc.'s EPS (diluted) has grown at a 95.9% compound annual growth rate (CAGR), from -$0.35 to -$5.15.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Evolent Health, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude